SCHEDULE I - CONDENSED FINANCIAL INFORMATION OF REGISTRANT (Details 3) (USD $) In Millions, unless otherwise specified	3 Months Ended								12 Months Ended			3 Months Ended	12 Months Ended
	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2011 Ameriprise Financial, Inc:	Dec. 31, 2013 Ameriprise Financial, Inc:	Dec. 31, 2012 Ameriprise Financial, Inc:	Dec. 31, 2011 Ameriprise Financial, Inc:
Cash Flows from Operating Activities
Net income	$ 380	$ 449	$ 281	$ 365	$ 332	$ 151	$ 170	$ 248	$ 1,475	$ 901	$ 1,010		$ 1,334	$ 1,029	$ 1,116
Equity in earnings of subsidiaries excluding discontinued operations													(1,570)	(1,235)	(1,340)
Loss from discontinued operations, net of tax	2	(1)	1	1	(1)	1	1	1	3	2	60		3	2	60
Dividends received from subsidiaries													1,163	1,366	1,210
Other operating activities, primarily with subsidiaries													(34)	197	(231)
Net cash provided by operating activities									1,364	1,505	2,178		896	1,359	815
Cash Flows from Investing Activities
Proceeds from sales									327	3,719	888		2	0	0
Maturities, sinking fund payments and calls									5,101	4,994	5,206		191	30	239
Purchases									(5,780)	(4,957)	(7,236)		(109)	0	(22)
Proceeds from sale of other investments													43	1	0
Purchase of other investments									(347)	(403)	(422)		(1)	(55)	0
Purchase of land, buildings, equipment and software									(105)	(137)	(250)		(54)	(38)	(56)
Contributions to subsidiaries													(106)	(131)	(128)
Return of capital from subsidiaries													470	347	22
Proceeds from sale of business									0	0	150	150	0	0	150
Repayment of loans from subsidiaries													1,420	1,150	1,252
Issuance of loans to subsidiaries													(1,412)	(994)	(1,312)
Other, net									46	8	(9)		20	(16)	2
Net cash provided by (used in) investing activities									(802)	4,417	(1,146)		464	294	147
Cash Flows from Financing Activities
Dividends paid to shareholders									(401)	(305)	(212)		(401)	(305)	(212)
Repurchase of common shares									(1,583)	(1,381)	(1,495)		(1,583)	(1,381)	(1,495)
Cash paid for purchased options with deferred premiums													(4)	0	0
Cash received for purchased options with deferred premiums													23	0	0
Issuance of debt, net of issuance costs									744	0	0		744	0	0
Repayments of debt									(350)	0	(20)		(350)	0	(14)
Exercise of stock options									118	160	66		118	160	66
Excess tax benefits from share-based compensation									120	64	90		120	64	90
Other, net									15	(4)	0		(2)	(3)	(1)
Net cash used in financing activities									(306)	(6,342)	(1,111)		(1,335)	(1,465)	(1,566)
Net increase (decrease) in cash and cash equivalents									261	(410)	(80)		25	188	(604)
Cash and cash equivalents at beginning of period				2,371				2,781	2,371	2,781	2,861		900	712	1,316
Cash and cash equivalents at end of period	2,632				2,371				2,632	2,371	2,781	712	925	900	712
Supplemental Disclosures:
Interest paid on debt													129	139	139
Income Taxes Paid, Net									391	217	370		354	170	334
Non-cash capital transactions to (from) subsidiaries													0	0	(850)
Non-cash Financing activity:
Dividends declared but not paid	$ 0				$ 0				$ 0	$ 0	$ 62	$ 62	$ 0	$ 0	$ 62